Cas:123278-01-3 4′-methoxyagarotetrol manufacturer & supplier

We serve Chemical Name:4′-methoxyagarotetrol CAS:123278-01-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

4'-methoxyagarotetrol

Chemical Name:4′-methoxyagarotetrol
CAS.NO:123278-01-3
Synonyms:4′-methoxyagarotetrol
Molecular Formula:C18H20O7
Molecular Weight:348.35
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:
Exact Mass:
LogP:

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 4′-methoxyagarotetrol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4′-methoxyagarotetrol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4′-methoxyagarotetrol Use and application,4′-methoxyagarotetrol technical grade,usp/ep/jp grade.


Related News: The findings challenge past, smaller studies that found Black women face a greater genetic risk and the suggestion that race should be an independent factor when considering genetic testing,” said study first author Dr. Susan Domchek, executive director of the Basser Center for BRCA at the University of Pennsylvania’s Perelman School of Medicine.
“We shouldn’t make changes to testing guidelines based on race alone,” she said in a university news release. “Rather, our efforts should focus on ensuring equal access to and uptake of testing to minimize disparities in care and outcomes. 4′-methoxyagarotetrol manufacturer In the context of the new medicine policy, with the development of China’s R & D strength, the number of innovative drugs approved has been blown out, which further strengthened the demand and speed of industrialization of raw materials in China. 4′-methoxyagarotetrol supplier Taking Teva as an example, it has 2 large R & D centers and 3 professional R & D centers in 5 countries, which effectively supports the development of Teva’s generic pharmaceutical sector. 4′-methoxyagarotetrol vendor The findings challenge past, smaller studies that found Black women face a greater genetic risk and the suggestion that race should be an independent factor when considering genetic testing,” said study first author Dr. Susan Domchek, executive director of the Basser Center for BRCA at the University of Pennsylvania’s Perelman School of Medicine.
“We shouldn’t make changes to testing guidelines based on race alone,” she said in a university news release. “Rather, our efforts should focus on ensuring equal access to and uptake of testing to minimize disparities in care and outcomes. 4′-methoxyagarotetrol factory ��Ultimately, this is a public health decision,�� she said, adding that the restrictions were precautionary measures to keep the country virus-free and contain the worldwide outbreak.